T. Rowe Price Investment Management »

Maplight Therapeutics shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $49M 2.8M 17.57

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Alphabet Comm Stk (GOOGL)
Amazon Comm Stk (AMZN)
PTC Comm Stk (PTC)
Becton Dickinson & Co Comm Stk (BDX)
Yum Brands Comm Stk (YUM)
Cencora Comm Stk (COR)
Abbott Labs Comm Stk (ABT)
Centerpoint Energy Comm Stk (CNP)
Revvity Comm Stk (RVTY)
Nisource Comm Stk (NI)
Meta Platforms Comm Stk (META)
Broadcom Comm Stk (AVGO)

View all positions for T. Rowe Price Investment Management

Top funds holding Maplight Therapeutics

T. Rowe Price Investment Management
Goldman Sachs Group
Vanguard Group
Geode Capital Management
State Street Corporation
Lazard Asset Management
Freestone Grove Partners
Bnp Paribas Investment Partners
Charles Schwab Investment Management
Marshall Wace
TD Asset Management
Bank of New York Mellon
Barclays
Wells Fargo & Company
UBS Group

View all funds holding Maplight Therapeutics